chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LEFT ARM NUMBNESS; LEG CRAMPING; NUMBNESS UNDER LEFT EYE; NAUSEA; CHEST PRESSURE; SEVERE HEADACHES; This spontaneous report received from a parent concerned a 43 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose not reported, on approximately 08-APR-2021 for prophylactic vaccination.The batch number was not reported and has been requested. No concomitant medications were reported.The patient was not pregnant at the time of report. Patient had the Janssen Covid-19 vaccine on approximately 08-APR-2021 and started experiencing side effects on 14-APR-2021 (six days later) which included severe headaches, nausea, left arm numbness, cramping in one leg, and chest pressure. Patient went to Emergency room several times for these symptoms and was discharged each time. Patient also had numbness under left eye and was admitted to hospital on or about 16-APR-2021 or 17-APR-2021 to rule out blood clot on MRI and was diagnosed with arachnoid granulation and released on 20-APR-2021. Patient was hospitalized for approximately 3-4 days. Patient then started with chest pressure, slight headache and leg cramping and went to Emergency room on evening of 02-MAY-2021.On an unspecified date in  APR-2021, Laboratory data included: MRI(Magnetic resonance imaging) (NR: not provided) arachnoid granulation. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chest pressure, severe headaches, left arm numbness, leg cramping, numbness under left eye and nausea was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- 20210504059- Covid-19 vaccine ad26.cov2.s- left arm numbness, leg cramping, numbness under left eye. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the event. 20210504059-covid-19 vaccine ad26.cov2.s nausea. This event is labeled per RSI and is therefore considered potentially related.
10 am (8/13/13) SQ Varicella given left deltoid. Slight bleeding at site. 10:03 am pt states not feeling well, weak, thirsty, asking for water. Sweating at face, upper exts, apprehensive. BP 6/0. 10:04 Epinephrin 0.3 mg rt outer thigh given. 10:04 BP 94/48. 10:05 pulse stronger BP 104/50. 10:10 HR 63 BP 105/51. in 15 BP 104/60 stood up, states feeling well. 11 am left to go home.
Patient reported flu like symptoms evening after receiving the shot. Pt reported chills and a fever of over 100 degrees.
Weakness, neuralgic/achey feeling, light-headedness, loss of appetite, swollen throat and head. No fever, but felt like I had a fever.  This condition has now lasted with only minor relief for 4 weeks.  Note: I had begun taking an antibiotic (Amoxicillin) for the gum-infection the same evening of the day I got the flu-shot. My doctor said there should have been no co-relation to my symptoms.
I saw my cardiologist for a routine, six-month exam on 12/9/2022. I underwent an electrocardiogram. My cardiologist told me that my blood flow was slow. She said that this sometimes happens with some people, but in my case, she wanted to make sure I didn't have any blockages. At that point, I was sent to the blood bank to undergo a blood draw and a test whose name I don't know. About an hour or two later, I got a call asking me to come to the hospital to undergo a pulmonary CT scan with contrast dye. About an hour or so after undergoing the CT scan, I was instructed to go to the ER. I went to the ER and waited for a couple of hours to be seen. The ER doctor told me that I had some blood clots in my lungs. He asked me how I felt and wanted to know if I felt well enough to go home. He explained that pulmonary embolisms are now no longer treated the way they used to be. In the past, anyone with a pulmonary embolism would have automatically been hospitalized, but nowadays, if the patient feels well enough to go home, they are released, and the embolism is treated with medication. I was then prescribed Eliquis to treat the embolisms and then sent home. Nowadays, if I overexert myself, I can get a little winded. I went back to the cardiologist on 12/22/2022. I underwent an echocardiogram, and my cardiologist said that everything looked fine. I was also scheduled me for an exercise stress echocardiogram, which I am due to undergo later this month. I was originally told that I would be taking Eliquis for about three months, but on account of my history of previous heart issues, the MD told me that I would be taking 5mg of Eliquis twice a day for at least six months. After that point, they may put me on a lower maintenance dose.
vaccine Exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (vaccine Exposure during pregnancy) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Streptomycin). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 29-Dec-2020 to an unknown date for Pregnancy, ACETYLSALICYLIC ACID (ASPIRINE) from 29-Dec-2020 to an unknown date for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (vaccine Exposure during pregnancy). On 03-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccine Exposure during pregnancy) had resolved. Not Provided          No information provided about any treatment medications.  Action taken with mRNA-1273 in response to the event was not applicable.
Continued pain in my right arm and shoulder when I perform lateral motion, especially with some weight in my hand, like lifting a jug of milk or opening a heavy door.  The pain is so strong that it wakes me up at night.
Shingles; Information has been received regarding a case in litigation from a lawyer, a female patient of unknown age, and her spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 31-MAY-2017, at age 58, the patient was administered the zoster vaccine live (ZOSTAVAX) vaccine by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from her zoster vaccine live (ZOSTAVAX) use: Shingles. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown.  Additional information has been requested.
Migraine; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 11:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 14Apr2021 at 12:00, the patient experienced migraine headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine headache was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
PHANTOM SMELL OF CIGARETTE SMOKE (THERE IS NO ACTUAL SMOKE ANYWHERE NEARBY), RINGING IN THE YEAR, LEFT GRATER THAN RIGHT.  It is important to note that I already had Covid-19, twice.  The second time was in January of 2021 (just 3 -4 months ago).  At that time I lost my sense of smell and taste, and had ringing in my ear.  When smell and taste began to come back I had the phantom smell of cigarettes and that lasted until just a few weeks ago (I would say 4 -6 weeks ago it finally went away).   After the first dose of the Pfizer Vaccine (LOT NUMBER EN6203) taken at the same location as this second one, I experienced flu symptoms 24 hours later (vaccine date was 3/22/2021).   I had a fever and body aches and a very strong headache but both went away by the second day.   It was only after the second dose that I started to experience the phantom smell of cigarettes and the ringing in my ears once again.  I am not sure if it was triggered by the vaccine or if I was doomed and would have had it anyway, after all I experienced it for a while after Covid.   I also tested positive for antibodies in February.  So I probably still had the antibodies present in my body when I got both doses of the vaccine.
pop up rashes over his lower abdomen and chest. It looks like hives; Itching on his head, arms, wrists, feet and legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on his head, arms, wrists, feet and legs) and URTICARIA (pop up rashes over his lower abdomen and chest. It looks like hives) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced PRURITUS (Itching on his head, arms, wrists, feet and legs). On 19-Nov-2021, the patient experienced URTICARIA (pop up rashes over his lower abdomen and chest. It looks like hives). At the time of the report, PRURITUS (Itching on his head, arms, wrists, feet and legs) and URTICARIA (pop up rashes over his lower abdomen and chest. It looks like hives) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.
Caller got both doses of the Covid vaccine and within two and half weeks later after the 2nd dose she got Covid.; Caller got both doses of the Covid vaccine and within two and half weeks later after the 2nd dose she got Covid.; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program.   A female patient of an unspecified age received the 1st and the 2nd dose of BNT162b2 (BNT162B2, Batch/Lot number not reported), both an unspecified route of administration as single dose on an unspecified date for COVID-19 immunisation.  Medical history included Covid-19. She stated she had Covid twice before vaccination, before getting the Covid vaccine. The patient's concomitant medications were not reported.   Within two and half weeks after the 2nd dose the patient got Covid. She was in hospital 14 to15 days, she was on ventilator, she had very serious attack. The events were considered serious as per hospitalization and medically significant. She had Covid twice before this, before getting the Covid vaccine. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on an unknown date (before vaccination) and SARS-COV-2 test: positive on an unknown date (after vaccination). The outcome of the events was not reported.  Information about the Lot/batch number has been requested.
8/2/99 rxn to Td immunization 2inch diameter on lt arm erythema & inflammation;rxn began 8/1/99;
Mom in our clinic with patient to receive 4 month vaccines. Mom states after receiving 2 month vaccines her baby ended up hospitalized. He was unable to have a bowel movement and was screaming in pain. Took patient to ER and spent 5 days at the hospital. Negative for suspected Hirschsprung's. Upon following up with her pediatrician after discharge pediatrician states it could have been a possible adverse reaction related to ROTARIX vaccination.
Information has been received from a physician concerning a patient who was vaccinated with varicella virus vaccine live (Oka/Merck) and developed a severe local injection site reaction after receiving the vaccine. No further information was provided. This is one of two reports received from the same source. Additional information has been requested.
Patient came in 10/18 and said that her arm was still sore a week after her flu vaccination, and she had some "itching" near the injection area. She said her symptoms were confined to the injection area and started "a few days after the vaccine." No rash, redness, or swelling present. Patient denies any decrease in range of motion. Patient said she used some "body lotion", and this "helped" her itching. She was advised to continue using a moisturizer since this seemed to help her itchy skin and was told she could take an oral pain reliever if necessary to help with the pain in her arm. She was advised to follow up with her physician if symptoms did not resolve/got worse.
Medical assistant calling to report administered vaccine temperature excursion on multiple patients.; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 13-JUN-2022, the patient was vaccinated with improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 1 injection, lot #U036586, expiration date: 21-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided) (product storage error).  It was reported that the vaccine went out of range on 13-JUN-2022 (reported as "yesterday") and it was not discovered until the morning on 14-JUN-2022 when checking the data logger.  This is one of the cases reported by the same reporter. ; Sender's Comments:  US-009507513-2206USA004337:
This spontaneous report as received from a licensed practiced nurse refers to 3 patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. On 06-NOV-2015, the patients were vaccinated with improperly stored doses of GARDASIL 9 was vaccinated with improperly stored GARDASIL 9 (lot# was reported as L014239, expiration date 21-JUL-2017, dose and route were unknown). No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Beginning  about 34 hours after the second vaccine dose, she noted itching of her posterior neck, upper back and across the shoulders, behind both ears, and the injection site in the right deltoid region. Initially she only noted itching in all of the above areas and slight redness of the injection site. She took a single 25 mg dose of diphenhydramine that night and went to bed. The next morning when she woke, her ears were swollen and red, she had blotchy red areas on her face, and increased redness and swelling of the injection site in the right deltoid. She also noted small red "bumps" on her lower legs and thighs bilaterally and across her abdomen as well. She also noted pruritis of her left arm at this time. She took a 10 mg dose of zyrtec this morning around 7:30 AM and then went to an urgent care for evaluation. At the urgent, she was given an IM steroid injection and a prescription for a 5-day course of prednisone 40 mg qday. She has noted significant improvement since receiving the steroid injection earlier today and her symptoms and the skin lesions are nearly completely resolved at this time.
Erythema, induration, pain around injection site  6/27/08 Reviewed PCP medical records of 6/18/08.  Vax given at hospital 6/12/08.  Pt seen s/p hospitalization for a burn of left leg & foot.  Pneumovax injection site in RUE w/erythema, pain & induration.  Was on oral antibiotics for burn & had continued to have difficulty walking due to burn.    7/4/08 Reviewed hospital medical records of 6/10-6/12/2008. FINAL DX: Records reveal patient experienced kitchen grease partial thickness burn to left foot on 6/4/2008 w/increasing pain & swelling by 6/9-10/2008 & developed cellulitis.  Failed oral antibiotics & was hospitalized for IV antibiotics.  Responded well w/improvement in foot
Blood pressure was elevated; having daily mild chest pain; mild left neck tension/warm sensations; mild left neck tension/warm sensations; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 12:00 (at the age of 47-years-old) (Batch/Lot Number: ER8737) as single dose for COVID-19 immunisation. Medical history included Allergies to medications, food, or other products: Yeast intolerance. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. 10 days after 1st dose vaccination, on 10Apr2021, the patient started having daily mild chest pain and mild left neck tension/warm sensations. This was still continuing at this date. Blood pressure was elevated and saw physician and had blood work. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event was Unknown. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
NAUSEA; FEVER; PAIN; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 10:00 to Right Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-MAR-2021, the subject experienced nausea. On 07-MAR-2021, the subject experienced fever. On 07-MAR-2021, the subject experienced pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea, fever, and pain. This report was non-serious.
flu; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (age and gender unspecified) who had flu (Influenza), when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (Influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   Only time patient get the flu, when he/she get the shot.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Diarrhea 3 times the morning of Saturday, April 3rd, 2021. Body aches and chills started at around 10 am on Saturday, April 3rd, 2021 followed with a low grade fever of 99.9. Then took 1000 mg Tylenol around every 5-6 hrs. Fever didn't go down past 99.8 and went up to 101.8 for the next 48 hrs with body aches, chills, headache and exhaustion.
Urticaria and angioedema. I first broke out in hives at the back of my neck, the outside edges of my eyes, the insides and outsides of both elbows, and the fronts and backs of both knees. Hives are continuing to appear in various locations, usually bilateral. Saturday my throat felt like I had a stone in it when swallowing. On Monday my lips began to swell and I had heartburn. After taking massive doses of cetirizine and Benadryl the swelling in my lips went away. Skin reacts in welts to anything that scratches it.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Lot number: EN6201), in right arm, on 28Mar2021 as dose 2, single (Lot number: EN6199), in right arm, on 12Oct2021 as dose 3 (booster), single (Lot number: FF2587), in right arm and on 17Apr2022 at 16:00 as dose 4 (booster), single (Lot number: FK9893) at the age of 60 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "hypothyroidism" (unspecified if ongoing); "herpes II" (unspecified if ongoing), notes: Other medical history: herpes II. Concomitant medication(s) included: ARMOUR THYROID, start date: Dec1989; METOPROLOL, start date: Apr2021; VALACYCLOVIR HYDROCHLORIDE, start date: Dec2017. Past drug history included: Augmentin, reaction(s): "Known allergies: augmentin", notes: Known allergies: augmentin. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (Jun2022) Negative, notes: two days of negative tests; (Jun2022) Negative, notes: two days of negative tests. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Information: Anti-viral details included; Product: COVID 19 Treatment, Brand was Pfizer, Treatment start date was on 16Jun2022, Treatment Stop date was on 20Jun2022, Lot number was unknown, Indication was for treatment of COVID-19. After Paxlovid treatment, and two days of negative tests, symptoms came on very intensely 7 days after final dose. Much sicker than first illness with chest and head congestion, headache, cough. No fever. Adverse event start & time was 25Jun2022 at 12:00 PM. Patient was not recovered, and no treatment given for it.  No follow-up attempts possible. No further information expected.